Details of Metabolite
| Full List of Protein(s) Regulated by This Metabolite | ||||||
|---|---|---|---|---|---|---|
| Apolipoprotein (Apo) | ||||||
| Apolipoprotein A-I (APOA1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | APOA1 protein expression levels: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the decrease of APOA1 protein expression compared with control group. | |||||
| Chaperone protein (ChaP) | ||||||
| T-complex protein 1 beta (CCT2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | CCT2 protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of CCT2 protein expression compared with control group. | |||||
| Cofilin/tropomyosin actin-binding (CTAB) | ||||||
| Cofilin-1 (CFL1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | CFL1 protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of CFL1 protein expression compared with control group. | |||||
| GPCR rhodopsin (GPCR-1) | ||||||
| Oxoglutarate receptor (OXGR1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | OXGR1 protein activity levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of OXGR1 protein activity compared with control group. | |||||
| Hydrolases (EC 3) | ||||||
| Heat shock protein 90 alpha (HSP90A) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | HSP90AA1 protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of HSP90AA1 protein expression compared with control group. | |||||
| Proteasome zeta chain (PSMA5) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | PSMA5 protein expression levels: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the decrease of PSMA5 protein expression compared with control group. | |||||
| Intermediate filament (InFi) | ||||||
| Cytokeratin-1 (KRT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | KRT1 protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of KRT1 protein expression compared with control group. | |||||
| Isomerases (EC 5) | ||||||
| Protein disulfide-isomerase A2 (PDIA2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | PDIA2 protein expression levels: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the decrease of PDIA2 protein expression compared with control group. | |||||
| Rotamase A (PPIA) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | PPIA protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of PPIA protein expression compared with control group. | |||||
| Lyases (EC 4) | ||||||
| Alpha-enolase (ENO1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | ENO1 protein expression levels: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the decrease of ENO1 protein expression compared with control group. | |||||
| Carbonic anhydrase I (CA1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | CA1 protein expression levels: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the decrease of CA1 protein expression compared with control group. | |||||
| Fructose-bisphosphate aldolase A (ALDOA) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | ALDOA protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of ALDOA protein expression compared with control group. | |||||
| Oxidoreductases (EC 1) | ||||||
| Cytosolic malate dehydrogenase (MDH1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | MDH1 protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of MDH1 protein expression compared with control group. | |||||
| Glyceraldehyde-3-phosphate dehydrogenase 1 (GAPDH) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | GAPDH protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of GAPDH protein expression compared with control group. | |||||
| Peroxiredoxin-1 (PRDX1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | PRDX1 protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of PRDX1 protein expression compared with control group. | |||||
| Vesicle amine transport 1 (VAT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | VAT1 protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of VAT1 protein expression compared with control group. | |||||
| Serum albumin (ALB) | ||||||
| Albumin (ALB) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | ALB protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of ALB protein expression compared with control group. | |||||
| Somatotropin (Soma) | ||||||
| Prolactin (PRL) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | PRL protein expression levels: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the decrease of PRL protein expression compared with control group. | |||||
| Transferases (EC 2) | ||||||
| Phosphoglycerate kinase 1 (PGK1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | PGK1 protein expression levels: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the decrease of PGK1 protein expression compared with control group. | |||||
| Translocases (EC 7) | ||||||
| Vacuolar-type proton ATPase catalytic A (v-ATPase-A) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Oxoglutaric acid addition (336 hours) | |||||
| Induced Change | ATP6V1A protein expression levels: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Parkinsonism [ICD-11: 8A00] | |||||
| Details | It is reported that oxoglutaric acid addition causes the increase of ATP6V1A protein expression compared with control group. | |||||
| Full List of Protein(s) Regulating This Metabolite | ||||||
|---|---|---|---|---|---|---|
| Divalent anion:Na symporter (DASS) | ||||||
| Solute carrier family 13 member 2 (SLC13A2) | Click to Show/Hide the Full List of Regulating Pair(s): 5 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Mutation (T86C) of SLC13A2 | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that mutation (T86C) of SLC13A2 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Mutation (Y228C) of SLC13A2 | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that mutation (Y228C) of SLC13A2 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Regulating Pair (3) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Mutation (Y432C) of SLC13A2 | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that mutation (Y432C) of SLC13A2 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Regulating Pair (4) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Mutation (M539C) of SLC13A2 | |||||
| Induced Change | Oxoglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that mutation (M539C) of SLC13A2 leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Regulating Pair (5) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Mutation (N525C) of SLC13A2 | |||||
| Induced Change | Oxoglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that mutation (N525C) of SLC13A2 leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Solute carrier family 13 member 3 (SLC13A3) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] | ||||
| Introduced Variation | Mutation (Ala254Asp) of SLC13A3 | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that mutation (Ala254Asp) of SLC13A3 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] | ||||
| Introduced Variation | Mutation (Gly548Ser) of SLC13A3 | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that mutation (Gly548Ser) of SLC13A3 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| GPCR secretin (GPCR-2) | ||||||
| Glucagon receptor (GCGR) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] | ||||
| Introduced Variation | Knockout of Gcgr | |||||
| Induced Change | Oxoglutaric acid concentration: increase (FC = 2.3) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Type 2 diabetes mellitus [ICD-11: 5A11] | |||||
| Details | It is reported that knockout of GCGR leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Hydrolases (EC 3) | ||||||
| Leukotriene-C4 hydrolase (GGT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] | ||||
| Introduced Variation | Knockdown (siRNA) of GGT1 | |||||
| Induced Change | Oxoglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Renal cell carcinoma [ICD-11: 2C90] | |||||
| Details | It is reported that knockdown of GGT1 leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Phosphoinositide lipid phosphatase (PLIP) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] | ||||
| Introduced Variation | Knockout of Ptpmt1 | |||||
| Induced Change | Oxoglutaric acid concentration: decrease (FC= 0.50) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of Ptpmt1 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Mitochondrial carrier (MC) | ||||||
| Solute carrier family 25 member 21 (SLC25A21) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] | ||||
| Introduced Variation | Mutation (Lys232Arg) of SLC25A21 | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Muscular atrophy [ICD-11: 8B61] | |||||
| Details | It is reported that mutation (Lys232Arg) of SLC25A21 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Organic ion transporter (OIT) | ||||||
| Solute carrier family 22 member 7 (SLC22A7) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] | ||||
| Introduced Variation | Overexpression of SLC22A7 | |||||
| Induced Change | Oxoglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that overexpression of SLC22A7 leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Oxidoreductases (EC 1) | ||||||
| Alpha-ketoglutarate dehydrogenase (OGDH) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] | ||||
| Introduced Variation | Knockout of OGDH | |||||
| Induced Change | Oxoglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Cervical Cancer [ICD-11: 2C77] | |||||
| Details | It is reported that knockout of OGDH leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Formyltetrahydrofolate dehydrogenase (ALDH1L2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[11] | ||||
| Introduced Variation | Mutation of ALDH1L2 | |||||
| Induced Change | Oxoglutaric acid concentration: increase (FC = 2.78) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Genetic disorders of keratinisation [ICD-11: EC20] | |||||
| Details | It is reported that mutation (patients) of ALDH1L2 leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Green heme-binding protein (FLR) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[12] | ||||
| Introduced Variation | Knockout of BLVRB | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of BLVRB leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| L-lactate dehydrogenase C chain (LDHC) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[13] | ||||
| Introduced Variation | Knockout of Ldhc | |||||
| Induced Change | Oxoglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of Ldhc leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Oxalosuccinate decarboxylase (IDH1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[14] | ||||
| Introduced Variation | Mutation (R132H) of IDH1 | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Brain cancer [ICD-11: 2A00] | |||||
| Details | It is reported that R132H mutation of IDH1 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Transcription factor (TF) | ||||||
| Myc proto-oncogene protein (MYC) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[15] | ||||
| Introduced Variation | Knockdown (siRNA) of MYC | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
| Details | It is reported that knockdown of MYC leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Transferases (EC 2) | ||||||
| Deacetylase sirtuin-5 (SIRT5) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[16] | ||||
| Introduced Variation | Knockout of Sirt5 | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of Sirt5 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Isoprenylcysteine carboxylmethyltransferase (ICMT) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[17] | ||||
| Introduced Variation | Inhibition (Cysmethynil) of ICMT | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Breast cancer [ICD-11: 2C60] ... | |||||
| Details | It is reported that inhibition of ICMT leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Lipoyl synthase (LIAS) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[10] | ||||
| Introduced Variation | Mutation (R249H) of LIAS | |||||
| Induced Change | Oxoglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Cervical Cancer [ICD-11: 2C77] | |||||
| Details | It is reported that mutation (R249H) of LIAS leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[10] | ||||
| Introduced Variation | Knockout of LIAS | |||||
| Induced Change | Oxoglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Cervical Cancer [ICD-11: 2C77] | |||||
| Details | It is reported that knockout of LIAS leads to the increase of oxoglutaric acid levels compared with control group. | |||||
| Pyridoxal kinase (PDXK) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[18] | ||||
| Introduced Variation | Knockout (CRISPR/Cas9 sgRNA) of Pdxk | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Acute myeloid leukaemia [ICD-11: 2A60] | |||||
| Details | It is reported that knockout of Pdxk leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[18] | ||||
| Introduced Variation | Knockout (CRISPR/Cas9 sgRNA) of PDXK | |||||
| Induced Change | Oxoglutaric acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Acute myeloid leukaemia [ICD-11: 2A60] | |||||
| Details | It is reported that knockout of PDXK leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
| Transaldolase (TALDO1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[19] | ||||
| Introduced Variation | Knockout of Taldo1 | |||||
| Induced Change | Oxoglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of Taldo1 leads to the increase of oxoglutaric acid levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


